Chemical modifications and conjugation strategies that improve cellular uptake, membrane interaction, intracellular trafficking, endosomal escape and functional delivery of DNA, RNA, antisense, siRNA and therapeutic oligonucleotides.
Bio-Synthesis supports cell uptake-focused oligonucleotide modifications for programs where intracellular entry, trafficking or cytosolic availability limits biological activity.
This page focuses specifically on modifications used to improve cellular delivery and uptake, including cell-penetrating peptides, lipid and vitamin conjugates, nucleoside lipidations, glycan and receptor-assisted uptake ligands, endosomal escape peptides, PEG/TEG spacers, cleavable linkers and multivalent scaffolds.
Our team can help evaluate handle chemistry, conjugation site, linker length, hydrophobicity, solubility, purification, analytical QC and scale-up requirements for ASO, siRNA, ssDNA/dsDNA, ssRNA, probes and modified oligonucleotide constructs.
Instead of starting from a long product list, begin with the delivery barrier. Each strategy below connects the problem to the most practical modification class, design focus and QC consideration.
Use hydrophobic or lipid-like modifications when the main limitation is weak oligo interaction with the cell surface, membrane environment or serum-binding pathway.
Use CPP or localization peptides when cellular internalization needs active enhancement or when the payload requires stronger intracellular routing.
Use receptor-associated ligands when the target cell type expresses a relevant uptake receptor or when a receptor-context screen is part of the program.
Use escape and release chemistry when the oligo can enter cells but remains trapped, degraded or inactive before reaching its functional compartment.
Use the tabs to compare uptake-focused modification categories, product options, descriptions and common applications without turning the page into a long catalog.
Design note: CPP density can affect uptake, toxicity, solubility and purification. Evaluate linker length and placement early.
Design note: Hydrophobic modifiers can improve association but may reduce solubility or complicate purification. Balance potency with manufacturability.
Design note: Receptor-assisted uptake is most useful when receptor expression, attachment site and linker accessibility are considered together.
Design note: Pair uptake modifiers with a release strategy when endosomal trapping limits functional activity.
Cell delivery and uptake modifications are most useful when selected around the biological barrier, oligo modality and assay readout.
Use this table as a practical screening guide. Actual performance depends on sequence, chemistry pattern, cell type, linker, conjugation site, formulation and assay readout.
Ratings are qualitative design guides for selecting a starting point.
A successful cell delivery modification program connects uptake biology with conjugation design, oligo synthesis, purification and analytical release.
Define uptake, trafficking, endosomal release or localization challenge.
Select CPP, lipid, glycan, ligand, spacer or cleavable linker.
Synthesize DNA, RNA, ASO, siRNA or probe with compatible handle.
Attach modifier using selected chemistry, spacer and orientation.
Use HPLC/UPLC, desalting or method-matched cleanup.
Release with purity, identity, concentration, CoA and packaging.
Bio-Synthesis supports analytical characterization strategies for cell uptake-modified oligonucleotides using methods that evaluate purity, identity, conjugate profile, solubility, concentration and release-critical attributes.
Hydrophobic and peptide-conjugated oligos may require method-matched purification and QC because cellular uptake modifiers can change chromatographic behavior, solubility and mass confirmation strategy.
Purity assessment and chromatographic profile for modified oligos.
Mass identity confirmation where compatible with construct size and chemistry.
Quantitation, normalization and formulation-ready concentration reporting.
Optional endotoxin, residuals, solubility, stability and plate formatting.
Plan purification and handling around lipid load and solubility.
Confirm modified oligo profile and attachment where method-compatible.
µmol screens to larger supply, tubes, vials, plates, labels and barcodes.
Cell delivery-modified oligonucleotides require controlled synthesis, conjugation, purification and analytical release methods matched to the modifier and application.
Bio-Synthesis supports design, synthesis, conjugation, purification, analytical characterization and documentation for uptake-enabled oligonucleotide programs.
Connect cell uptake design with the appropriate Bio-Synthesis service workflow.
→
Compare CPP, lipid, glycan, receptor-assisted and endosomal escape approaches.
Purification, LC-MS, analytical purity, conjugate confirmation, labeling and documentation.
Use this section to support scientific credibility while keeping the page focused on cell uptake modification strategy, synthesis and analytical verification.
Suggested page note: Literature references are provided for scientific background. Final uptake-modified oligonucleotide design should be evaluated within the sequence, modality, modifier, linker, purification method, analytical QC and application model.
Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.